mAbDx and MitoSciences/Abcam sign Master Project Agreement

Tue 17 January 2012

mAbDx and MitoSciences/Abcam sign Master Project Agreement for mAbDx to develop medical/clinical diagnostics for:  1) sepsis, 2) SIRS (Systemic Inflammatory Response Syndrome), 3) HNSCC (Head and Neck Squamous Cell Carcinoma), 4) preeclampsia, and 5) inherited diseases affecting mitochondrial OXPHOS complexes I and IV.